Login to Your Account

Experimental Biology 2018

G proteins join kinases as druggable cancer targets

By Anette Breindl
Senior Science Editor

Wednesday, April 25, 2018

SAN DIEGO – Collectively, G protein-coupled receptors (GPCRs) are a treasure trove of drug targets. Somewhere between 30 and 50 percent of FDA-approved therapeutics are thought to work by targeting GPCRs.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription